Abstract:Background Diagnosis of colorectal cancer (CRC) during early stages can greatly improve patient outcome. Although technical advances in the field of genomics and proteomics have identified a number of candidate biomarkers for non-invasive screening and diagnosis, developing more sensitive and specific methods with improved cost-effectiveness and patient compliance has tremendous potential to help combat the disease. Methods We enrolled three cohorts of 479 subjects, including 226 CRC cases, 197 healthy controls, and 56 advanced precancerous lesions (APC). In the discovery cohort, we used quantitative mass spectrometry to measure the expression profile of plasma proteins and applied machine-learning to select candidate proteins. We then developed a targeted mass spectrometry assay to measure plasma concentrations of seven proteins and a logistic regression classifier to distinguish CRC from healthy subjects. The classifier was further validated using two independent cohorts. Results The seven-protein panel consisted of leucine rich alpha-2-glycoprotein 1 (LRG1), complement C9 (C9), insulin-like growth factor binding protein 2 (IGFBP2), carnosine dipeptidase 1 (CNDP1), inter-alpha-trypsin inhibitor heavy chain 3 (ITIH3), serpin family A member 1 (SERPINA1), and alpha-1-acid glycoprotein 1 (ORM1). The panel classified CRC and healthy subjects with high accuracy, since the area under curve (AUC) of the training and testing cohort reached 0.954 and 0.958. The AUC of the two independent validation cohorts was 0.905 and 0.909. In one validation cohort, the panel had an overall sensitivity, specificity, positive predictive value (PPV), and negative predictive value (NPV) of 89.9%, 81.8%, 89.2%, and 82.9%, respectively. In another blinded validation cohort, the panel classified CRC from healthy subjects with a sensitivity of 81.5%, specificity of 97.9%, and overall accuracy of 92.0%. Finally, the panel was able to detect APC with a sensitivity of 49%. Conclusions This seven-protein classifier is a clear improvement compared to previously published blood-based protein biomarkers for detecting early-stage CRC, and is of translational potential to develop into a clinically useful assay.

Molecular Staging with CM10 ProteinChip and SELDI-MS-TOF for Colorectal Cancer Patients Before Surgery.

Preoperatively Molecular Staging with CM10 ProteinChip and SELDI-TOF-MS for Colorectal Cancer Patients

Proteomic Diagnosis Models from Serum for Early Detection of Oral Squamous Cell Carcinoma.

[Preoperative molecular staging of colorectal cancers by CM10 ProteinChip and SELDI-TOF-MS analysis].

Laser-capture microdissection and protein extraction for protein fingerprint of OSCC and OLK.

Study of distinct serum proteomics for the biomarkers discovery in colorectal cancer.

Research on the biomarkers for the prediction of efficacy in first-line chemotherapy of metastatic colorectal cancer using SELDI-TOF-MS

Protein Fingerprint of Colorectal Cancer, Adenomatous Polyps, and Normal Mucosa Using ProteinChip Analysis on Laser Capture Microdissected Cells.

Diagnosis of pancreatic adenocarcinoma using protein chip technology.

A Serum Proteomic Pattern for the Detection of Colorectal Adenocarcinoma Using Surface Enhanced Laser Desorption and Ionization Mass Spectrometry

A Proteomic Classifier Panel for Early Screening of Colorectal Cancer: a Case Control Study

Evaluation of the Effectiveness of a Chemoprevention Model of Pancreatic Adenocarcinoma Using Protein Chip Technology.

Proteomic Biomarker Predicts Therapeutical Effects of Oxaliplatin Combining with Fluoropyrimidine in Metastatic Gastric Cancer Patients by the SELDI-proteinchip Platform.

Proteome analysis and tissue microarray for profiling protein markers associated with lymph node metastasis in colorectal cancer.

Limitations in Seldi-Tof Ms Whole Serum Proteomic Profiling with Imac Surface to Specifically Detect Colorectal Cancer

Diagnostic and Prognostic Application of Proteomic Patterns in Breast Cancer

Serum metabolite profiling of human colorectal cancer using GC-TOFMS and UPLC-QTOFMS.

[Establish Predictive Model of Colorectal Cancer by Using Surface Enhanced Laser Desorption/ionization-Time of Flight-Mass Spectrometry].

[Application of Serum Protein Pattern Model in Diagnosis of Colorectal Cancer].

[Classification and Diagnostic Prediction of Colorectal Cancer Using Protein Profiling of Serum and Bioinformatics].

Study of Distinct Protein Profiles for Early Diagnosis of NSCLC Using LCM and SELDI-TOF-MS